ZYXI
Zynex Inc
Halal Rating :
See Details
Last Price
$7.80
Last updated:
Market Cap
$274.83m
7D Change
-13.43%
1 Year Change
-9.83%
Company Overview
Industries
Exchange
Nasdaq
Next Earnings Date
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $49.97m | $46.16m | - | - | 0.00% | 0.00% |
| June 30, 2024 | $49.88m | $47.66m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $46.53m | $46.52m | - | $512000.0 | 0.00% | 1.10% |
Company Impact
Help us evaluate Zynex Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.